Round-up
May’s top news stories
Takeda to divest dry eye drug to Novartis in $5.3bn deal Takeda Pharmaceutical signed an agreement to sell its Xiidra…
April’s top news stories
Novartis to buy IFM Tre for up to $1.57bn Novartis agreed to acquire anti-inflammatory group IFM Tre, a subsidiary of…
February’s top news stories
Top pharma executives testify before US Senate over high prices Top executives from seven major pharmaceutical companies have appeared before the…
January’s top news stories
BMS acquires Celgene for an equity value of $74bn Bristol-Myers Squibb (BMS) has entered into a definitive merger agreement to…
M&As this week: Strides Pharma Science, Lambda Therapeutic Research, NextPharma
Strides Pharma Science’s step-down subsidiary Strides Pharma has made an arrangement to acquire Vensun Pharmaceuticals for $18m. Strides has agreed…